You are here: Industry Insights > CellGenix

News List

Sartorius Strengthens Cell and Gene Therapy Portfolio With Majority Stake of CellGenix americanpharmaceuticalreview
July 05, 2021
Sartorius acquired a majority stake in the reagent manufacturer CellGenix, a German producer and marketer of cell culture components including - growth factors, cytokines and media in GMP quality for manufacturing cell and gene therapy products.
CellGenix Expands Facility contractpharma
October 15, 2020
CellGenix GmbH, a global supplier of raw and ancillary materials for cell and gene therapies, has completed the second phase of its facility expansion.
Ori Biotech and CellGenix Collaborate contractpharma
May 14, 2020
Ori Biotech Ltd, an innovator in cell and gene therapy (CGT) manufacturing, and CellGenix GmbH, a global supplier of raw and ancillary materials for CGT and regenerative medicine, have announced a non-exclusive strategic partnership ...
CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents b3cnewswire
July 04, 2018
CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters’ expansion as more customers approach late-stage clinical develop
CellGenix Appoints Leading Experts to Scientific Advisory Board b3cnewswire
May 16, 2017
CellGenix announced the appointment of highly experienced and internationally respected experts in the field of cell and gene therapy to its Scientific Advisory Board (SAB).
CellGenix headquarters expands to meet the increasing demands for GMP cell culture reagents pharmaasia
March 10, 2017
CellGenix, a global manufacturing leader started facility expansions as more customers approach late-stage clinical development and commercialization.